These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 429553)

  • 1. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.
    Pollack M; Young LS
    J Clin Invest; 1979 Feb; 63(2):276-86. PubMed ID: 429553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core.
    Pollack M; Huang AI; Prescott RK; Young LS; Hunter KW; Cruess DF; Tsai CM
    J Clin Invest; 1983 Dec; 72(6):1874-81. PubMed ID: 6358257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive hemagglutination reaction using formalinized sheep erythrocytes treated with tannic acid and coated with exotoxin of Pseudomonas aeruginosa.
    Takeshi K; Homma JY
    Jpn J Exp Med; 1978 Dec; 48(6):497-501. PubMed ID: 108439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoserology of Pseudomonas aeruginosa infections in man. II. effect of natural and immune anti-LPS antibodies on pseudomonas colonization and infection.
    Petrás G; Adám MM; Lányi B; Konkoly Thege M; Szentmihályi A
    Acta Microbiol Hung; 1984; 31(2):101-8. PubMed ID: 6431739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections.
    Pollack M; Longfield RN; Karney WW
    Am J Med; 1983 Jun; 74(6):980-7. PubMed ID: 6407308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.
    Pollack M; Taylor NS
    J Clin Microbiol; 1977 Jul; 6(1):58-61. PubMed ID: 407250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.
    Pollack M; Callahan LT; Taylor NS
    Infect Immun; 1976 Oct; 14(4):942-7. PubMed ID: 825470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoserology of Pseudomonas aeruginosa infections in man. I. Four types of interaction between host and bacterium.
    Petrás G; Adám MM; Lányi B; Szentmihályi A; Konkoly Thege M
    Acta Microbiol Hung; 1984; 31(2):91-100. PubMed ID: 6431740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
    Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
    J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
    Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
    Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibody response to enterobacteriaceae and pseudomonas of patients with malignancies complicated by bacteremia.
    Neter E; Praino MD; Griffiths EK; Surgalla MJ; Fitzpatrick JE
    Zentralbl Bakteriol Orig A; 1979 Apr; 243(2-3):349-54. PubMed ID: 377859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1983 Mar; 39(3):1072-9. PubMed ID: 6404817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteremia and specific antibody response. IgG and IgM specificity in the evaluation of positivity in blood cultures].
    Airò R; Carusillo MG; Ferrari CM; Perucci MG; Rivetti I; Vaiani R
    Boll Ist Sieroter Milan; 1982; 61(6):460-72. PubMed ID: 6821448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the ELISA (lipopolysaccharide) and Widal reactions (O antigen) in the diagnosis of Salmonella infections].
    Hirschl A; Stanek G; Rotter M; Niemetz AH; Diridl G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):247-57. PubMed ID: 6196925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.